We at Cellgenemedix are involved in sending patients to the One World Clinic in South Korea. The One World Clinic owns exclusive genomic test technology which can solve the below medical problems and guide tailor made health care and tailor-made therapy of incurable diseases such as advanced cancer, in South Korea and we plan to expend in Kazakhstan and parts of Mexico. The business plan is as follows:
The clinic primarily focuses on saving patients with “difficult-to treat diseases or incurable diseases” which failed by conventional therapy. Major target diseases will include followings:
- Cancer of any cell type (usually stage 4 cancer patients, but can also include stage 2-3 cancer which underwent therapy in America, but needs additional treatment because of recurrent or remaining tumor, or needs strict follow up and care because of high risk of cancer coming back)
- Degenerative brain diseases (such as Parkinson’s disease, dementia and some cases of autism),
- Liver diseases (such as chronic hepatitis, liver cirrhosis),
- Diabetes mellitus (focused on patients with type 1 DM, but can also include those with type 2 DM failed by conventional therapy),
- Autoimmune diseases, such as lupus or SLE, immune mediated thrombocytopenic purpura or ITP, immune mediated inflammation of kidney (glomerulonephritis), joint (rheumatoid arthritis), lung (bronchial asthma), skin (psoriasis, atopy, etc), thyroid (autoimmune thyroiditis) and other organs
- Organ failure such as kidney failure, erectile dysfunction (impotence)
The clinic carry outs genetic testing in each patient and based on its result, will design and administer tailor made drug/gene/cell combination therapy, which will provide best chance of success and long term cure while avoiding side effects.
Contact: Cellgenemedix, Corp
243 Broadway #9188 Newark, NJ 07104
Tel+1-832-468-6985 Fax: +1 516 953 3453
www.cellgenemedix.com